Coronary Artery Bypass Grafting in a Patient with Myasthenia Gravis
DOI:
https://doi.org/10.1532/HSF98.2014383Abstract
A 70-year-old male patient with myasthenia gravis required coronary artery bypass grafting due to triple-vessel disease. The anesthetic management was performed with general anesthesia using reduced doses of muscle relaxants. He was extubated four hours after surgery and the postoperative course was uneventful. Coronary artery bypass surgery in myasthenic patients can be challenging to anesthesiologists and cardiac surgeons. In this rare condition, a meticulous assessment of the patient's neurologic and cardiac status, and careful perioperative anesthetic management were needed in order to avoid life-threatening complications in both intraoperative and postoperative periods.References
Asai K, Suzuki K, Washiyama N, Terada H, Yahashita K, Kazui T. 2004. Combined operation for myasthenia gravis and coronary artery disease. J Thorac Cardiovasc Surg 52:65-7.nBaraka A, Haroun-Bizri S, Kawas N. 1999. Cisatracurium in the myasthenic patient. Can J Anesth 46:779-82.nBlichfeldt-Lauridsen L, Hansen BD. 2012. Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand 56:17-22.nBuzello W, Noeldge G, Krieg N, Brobmann GF. 1986. Vecuronium for muscle relaxation in patients with myasthenia gravis. Anesthesiology 64:507-9.nHaroun-Bizri S, Maalouli J, Deeb P, Baraka A. 2003. Anesthetic management for a patient with myasthenia gravis undergoing coronary artery bypass graft. Middle East J Anesthesiol 17:299-305.nHayashida N, Kawara T, Akasu K, Kai E, Kosuga T, Chihara S, et al. 2000. Coronary artery bypass surgery in a patient with myasthenia gravis. Kurume Med J 47:173-5.nHunter JM, Bell CF, Florence AM, Jones RS, Utting JE. 1985. Vecuronium in the myasthenic patient. Anaesthesia 40:848-53.nIshimura H, Sata T, Matsumoto T, Takizura A, Shiqematsu A. 1998. Anesthetic management of a patient with myasthenia gravis during hypothermic cardiopulmonary bypass. J Clin Anesth 10:228-31.nLindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. 1998. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 51:933-9.nMcCarthy GJ, Mirakhur RK, Pandit SK. 1992. Lack of interaction between propofol and vecuronium. Anesth Analg 75:536-8.nNarin C, Sarkilar G, Tanyeli O, Ege E, Yeniterzi M. 2009. Successful mitral valve surgery in a patient with myasthenia gravis. J Card Surg 24:210-2.nOsserman KE, Genkis G. 1971. Studies in myasthenia gravis: review of twenty years experience in over 120 patients. MT Sinai J Med 38:497-537.nPaterson IG, Hood JR, Russel SH, Weston MD, Hirsch NP. 1994. Mivacurium in the myasthenic patient. Br J Anaesth 73:494-8.nPeacock JE, Cruickshank RH. 1989. Anaesthesia and rare diseases. Anesthesia. Nimmo WS, Smith G (eds). Blackwell Scientific Publications; 792-804.nRaimond F, Morel E, Bach JF. 1984. Evidence for the presence of immunoreactive acetylcholine receptors on human thymus cells. J Neuroimmunol 6:31-4.nRudzka-Nowak A, Piechota M. 2011. Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex. Arch Med Sci 7:361-4.nSanfilippo M, Fierro G, Cavalletti MV, Biancari F, Vilardi V. 1997. Rocuronium in two myasthenic patients undergoing thymectomy. Acta Anaesthesiol Scand 41:1365-6.nSungur Ulke Z, Senturk M. 2009. Mivacurium in patients with myasthenia gravis undergoing video-assisted thoracoscopic thymectomy. Br J Anesth 103:310-11.nUnterbuchner C, Fink H, Blobner M. 2010. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 65:302-5.nVincent A, Palace J, Hilton-Jones D. 2001. Myasthenia gravis. Lancet 357:2122-8.nYuan HK, Huang B-S, Kung S-Y, Kao KP. 2007. The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases. Acta Neurol Scand 115:181-4.n
